Attitudes toward participation in breast cancer randomized clinical trials in the African American community: A focus group study

Cancer Nursing

Volumn 30, Issue 4, 2007, Pages 261-269

  Linden, Hannah M ^a,e   Reisch, Lisa M ^b   Hart Jr , Alton ^c   Harrington, Margaret A ^b   Nakano, Connie ^d   Jackson, J Carey ^b   Elmore, Joann G ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Breast cancer; Clinical trials; Focus group study

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATTITUDE TO HEALTH; BREAST CANCER; CANCER SCREENING; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; PERSONNEL; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL; RELIGION; RISK;

ADULT; AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; FEMALE; FOCUS GROUPS; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; WASHINGTON;

EID: 34547601769     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NCC.0000281732.02738.31     Document Type: Article

References (52)

1. Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer. 1996;77(2):308-314.
2. Brawley OW. Some perspective on black-white cancer statistics. CA Cancer J Clin. 2002;52(6):322-325.
3. Brawley OW. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst. 2002;94(7):471-473.
4. Ghafoor A, Jemal A, Cokkinides V, et al. Cancer statistics for African Americans. CA Cancer J Clin. 2002;52(6):326-341.
5. In: Smedley BD, Stith A, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2002. Issued by the Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Board on Health Sciences Policy.
6. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334-357.
7. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106- 2113.
8. Perkins P, Cooksley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer. 1996;78(6):1241-1247.
9. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term?) Evidence for a "trial effect." J Clin Epidemiol. 2001;54(3):217-224.
10. Killien M, Bigby JA, Champion V, et al. Involving minority and under-represented women in clinical trials: the National Centers of Excellence in Women's Health. J Women's Health Gend-Based Med. 2000;9(10):1061-1070.
11. Stark N, Paskett E, Bell R, et al. Increasing participation of minorities in cancer clinical trials: summary of the "Moving Beyond the Barriers" Conference in North Carolina. J Natl Med Assoc. 2002;94(1):31-39.
12. Healthy People 2010. Conference ed. Washington, DC: Department of Health and Human Services; 2000.
13. Freedman LS, Simon R, Foulkes MA, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 - the perspective of NIH clinical trialists. Control Clin Trials. 1995;16(5):277-285.
14. Daugherty CK, Ratain MJ, Minami H, et al. Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol. 1998;16(7):2305-2312.
15. Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19(6):1728-1733.
16. Fisher B. On clinical trial participation. J Clin Oncol. 1991;9(11):1927-1930.
17. Thompson IM, Coltman CA, Brawley O, Ryan A. Chemoprevention of prostate cancer. Semin Urol. 1995;13(2):122-129.
18. Chlebowski RT, Butler J, Nelson A, Lillington L. Breast cancer chemoprevention. Tamoxifen: current issues and future perspective. Cancer. 1993;72(3 suppl):1032-1037.
19. Shavers VL, Lynch C, Burmeister LF. Factors that influence African-Americans' willingness to participate in medical research studies. Cancer. 2001;91(S1):233-236. Erratum in: Cancer. 2001;91(6):1187.
20. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334-357.
21. Fouad MN, Partridge E, Green BL, et al. Minority recruitment in clinical trials: a conference at Tuskegee, researchers and the community. Ann Epidemiol. 2000;10(8 suppl):S35-S40.
22. Gamble VN. A legacy of distrust: African Americans and medical research. Am J Prev Med. 1993;9(6 suppl):35-38.
23. Corbie-Smith G. The continuing legacy of the Tuskegee Syphilis Study: considerations for clinical investigation. Am J Med Sci. 1999;317(1):5-8.
24. Kaluzny A, Brawley O, Garson-Angert D, et al. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst. 1993;85(23):1945-1950.
25. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003;21(5):830-835.
26. Denholm JT. The Declaration of Helsinki and research in vulnerable populations. Med J Aust. 2000;173(4):223-224.
27. Schuklenk U. Protecting the vulnerable: testing times for clinical research ethics. Soc Sci Med. 2000;51(6):969-977.
28. Daugherty CK, Siegler M, Ratain MJ, Zimmer G. Learning from our patients: one participant's impact on clinical trial research and informed consent. Ann Intern Med. 1997;126(11):892-897.
29. Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 2001;19(15):3554-3561.
30. Erlen JA. Clinical research: what do patients understand? Orthop Nurs. 2000;19(2):95-99.
31. Wager E, Tooley PJ, Emanuel MB, Wood SF. How to do it. Get patients' consent to enter clinical trials. BMJ. 1995;311(7007):734-737.
32. Woloshin KK, Ruffin MT 4th, Gorenflo DW. Patients' interpretation of qualitative probability statements. Arch Fam Med. 1994;3(11):961-966.
33. Davis TC, Crouch MA, Long SW, et al. Rapid assessment of literacy levels of adult primary care patients. Fam Med. 1991;23(6):433-435.
34. Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25(6):391-395.
35. Giuliano AR, Mokuau N, Hughes C, et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. Ann Epidemiol. 2000;10(8 suppl):S22-S34.
36. Morgan DL. Focus Groups as Qualitative Research. Thousand Oaks, Calif: Sage Publications; 1988.
37. In: Morgan DL, ed. Successful Focus Groups: Advancing the State of the Art. Newbury Park, Calif: Sage Publications; 1993.
38. Gerbert B, Caspars N, Bronstone A, Moe J, Abercrombie P. A qualitative analysis of how physicians with expertise in domestic violence approach the identification of victims. Ann Intern Med. 1999;131(8):578-584.
39. Phase III Randomized Study of Adjuvant Chemotherapy Comprising Standard Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) or Doxorubicin and Cyclophosphamide (AC) Versus Oral Capecitabine in Elderly Women With Operable Adenocarcinoma of the Breast, current study, available from the National Cancer Institute at: http://www.cancer.gov/search/viewclinicaltrials.aspx?cdrid= 68891&version=healthprofessional&protocolsearchid=2092582. Accessed February 8, 2006.
40. Shavers VL, Lynch CF, Burmeister LF. Racial differences in factors that influence the willingness to participate in medical research studies. Ann Epidemiol. 2002;12(4):248-256.
41. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med. 1999;14(9):537-546.
42. Davis TC, Williams MV, Marin E, Parker RM, Glass J. Health literacy and cancer communication. CA Cancer J Clin. 2002;52(3):134-149.
43. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995;87(23):1747-1759.
44. Roberson NL, Clinical Trial Participation. Viewpoints from racial/ethnic groups. Cancer. 1994;74(9 suppl):2687-2691.
45. Kagawa-Singer M. Improving the validity and generalizability of studies with underserved U.S. populations expanding the research paradigm. Ann Epidemiol. 2000;10(8 suppl):S92-S103.
46. Fouad MN, Partridge E, Wynn T, Green BL, Kohler C, Nagy S. Statewide Tuskegee Alliance for clinical trials. A community coalition to enhance minority participation in medical research. Cancer. 2001;19(1 suppl):237-241.
47. In: Haynes MA, Smedley BD, eds. The Unequal Burden of Cancer: An assessment of NIH Research and Programs for Ethnic Minorities and the Medically Underserved. Health Sciences Policy Program. Washington DC: The National Academy Press; 1999.
48. Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP. Do patients participating in clinical trials want to know study results? J Natl Cancer Inst. 2003;95(6):491-492.
49. Featherstone K, Donovan JL. Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ. 1998;317(7167):1177-1180.
50. Criscione LG, Sugarman J, Sanders L, Pisetsky DS, St Clair EW. Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum. 2003;49(3):361-367.
51. Lobb EA, Butow PN, Kenny DT, Tattersall MH. Communicating prognosis in early breast cancer: do women understand the language used. Med J Aust. 1999;171(6):290-294.
52. Felix Aaron K, Levine D, Burstin HR. African American church participation and health care practices. J Gen Intern Med. 2003;18(11):908-913.